Fri, April 1, 2022

Nicole Germino Maintained (ASMB) at Strong Buy with Decreased Target to $144 on, Apr 1st, 2022

Nicole Germino of Truist Securities, Maintained "Assembly Biosciences, Inc." (ASMB) at Strong Buy with Decreased Target from $180 to $144 on, Apr 1st, 2022.

Nicole, nor any peers, have made any analyst calls on ASMB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30